HELPING THE OTHERS REALIZE THE ADVANTAGES OF BLOCK PAIN RECEPTORS WITH PROLEVIATE

Obtaining determined the palmitoylation motif of APLNR, we intended a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web page in combination with morphine, can inhibit the development of NCP, like pain incidence, microglial activation, and inf